ArticleBritish journal of cancer2023

Ponatinib delays the growth of solid tumours by remodelling immunosuppressive tumour microenvironment through the inhibition of induced PD-L1 expression.

Anjali Barnwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.